Skip NavigationSkip to Content

NCI at Frederick Scientific Publications Advanced Search

Search

  1. NCI-F Publications

  2. Return to Quick Search
Search
  2. Year Published:

Your search returned 35 results.
User Information
Export Records
  1. 1.   Suppression of the C/EBP family of transcription factors in adipose tissue causes lipodystrophy
  2. Chatterjee, R.; Bhattacharya, P.; Gavrilova, O.; Glass, K.; Moitra, J.; Myakishev, M.; Pack, S.; Jou, W.; Feigenbaum, L.; Eckhaus, M.; Vinson, C.
  3. Journal of Molecular Endocrinology. 2011, Jun; 46(3): 175-192.
  1. 2.   Simultaneous down-regulation of tumor suppressor genes RBSP3/CTDSPL, NPRL2/G21 and RASSF1A in primary non-small cell lung cancer
  2. Senchenko, V. N.; Anedchenko, E. A.; Kondratieva, T. T.; Krasnov, G. S.; Dmitriev, A. A.; Zabarovska, V. I.; Pavlova, T. V.; Kashuba, V. I.; Lerman, M. I.; Zabarovsky, E. R.
  3. Bmc Cancer. 2010, Mar; 10: 13.
  1. 3.   HYAL1 and HYAL2 Inhibit Tumour Growth In Vivo but Not In Vitro
  2. Wang, F. L.; Grigorieva, E. V.; Li, J. F.; Senchenko, V. N.; Pavlova, T. V.; Anedchenko, E. A.; Kudryavtseva, A. V.; Tsimanis, A.; Angeloni, D.; Lerman, M. I.; Kashuba, V. I.; Klein, G.; Zabarovsky, E. R.
  3. Plos One. 2008, Aug; 3(8): 8.
  1. 4.   Autoimmunity, spontaneous tumourigenesis, and IL-15 insufficiency in mice with a targeted disruption of the tumour suppressor gene FusI
  2. Ivanova, A. V.; Ivanov, S. V.; Pascal, V.; Lumsden, J. M.; Ward, J. M.; Morris, N.; Tessarolo, L.; Anderson, S. K.; Lerman, M. I.
  3. Journal of Pathology. 2007, Apr; 211(5): 591-601.
  1. 5.   Expression of candidate chromosome 3p21.3 tumor suppressor genes and down-regulation of BLU in some esophageal squamous cell carcinomas
  2. Lo, P. H. Y.; Leung, A. C. C.; Xiong, W. J.; Law, S.; Duh, F. M.; Lerman, M. I.; Stanbridge, E. J.; Lung, M. L.
  3. Cancer Letters. 2006, Mar; 234(2): 184-192.
  1. 6.   Genetic variation in TNF and IL10 and risk of non-Hodgkin lymphoma: a report from the InterLymph Consortium
  2. Rothman, N.; Skibola, C. F.; Wang, S. S.; Morgan, G.; Lon, Q.; Smith, M. T.; Spinelli, J. J.; Willett, E.; De Sanjose, S.; Cocco, P.; Berndt, S. I.; Brennan, P.; Brooks-Wilson, A.; Wacholder, S.; Becker, N.; Hartge, P.; Zheng, T. Z.; Roman, E.; Holly, E. A.; Boffetta, P.; Armstrong, B.; Cozen, W.; Linet, M.; Bosch, F. X.; Ennas, M. G.; Holford, T. R.; Gallagher, R. P.; Rollinson, S.; Bracci, P. M.; Cerhan, J. R.; Whitby, D.; Moore, P. S.; Leaderer, B.; Lai, A.; Spink, C.; Davis, S.; Bosch, R.; Scarpa, A.; Zhang, Y. W.; Severson, R. K.; Yeager, M.; Chanock, S.; Nieters, A.
  3. Lancet Oncology. 2006, JAN; 7(1): 27-38.
  1. 7.   Coincident thresholds of mutant protein for paralytic disease and protein aggregation caused by restrictively expressed superoxide dismutase cDNA
  2. Wang, J.; Xu, G. L.; Slunt, H. H.; Gonzales, V.; Coonfield, M.; Fromholt, D.; Copeland, N. G.; Jenkins, N. A.; Borchelt, D. R.
  3. Neurobiology of Disease. 2005, DEC; 20(3): 943-952.
  1. 8.   Stromal cell-derived factor-1 genotype, coreceptor tropism, and HIV type 1 disease progression
  2. Daar, E. S.; Lynn, H. S.; Donfield, S. M.; Lail, A.; O'Brien, S. J.; Huang, W.; Winkler, C. A.
  3. Journal of Infectious Diseases. 2005, NOV 1; 192(9): 1597-1605.
  1. 9.   Allellic variants in regulatory regions of cyclooxygenase-2: association with advanced colorectal adenoma
  2. Ali, I. U.; Luke, B. T.; Dean, M.; Greenwald, P.
  3. British Journal of Cancer. 2005, OCT 17; 93(8): 953-959.
  1. 10.   Effect of common CYP3A4 and CYP3A5 variants on the pharmacokinetics of the cytochrome P450 3A phenotyping probe midazolam in cancer patients
  2. Lepper, E. R.; Baker, S. D.; Permenter, M.; Ries, N.; van Schaik, R. H. N.; Schenk, P. W.; Price, D. K.; Ahn, D.; Smith, N. F.; Cusatis, G.; Ingersoll, R. G.; Bates, S. E.; Mathijssen, R. H. J.; Verweij, J.; Figg, W. D.; Sparreboom, A.
  3. Clinical Cancer Research. 2005, OCT 15; 11(20): 7398-7404.
  1. 11.   Targeted disruption of mouse Coch provides functional evidence that DFNA9 hearing loss is not a COCH haploinsufficiency disorder
  2. Makishima, T.; Rodriguez, C. I.; Robertson, N. G.; Morton, C. C.; Stewart, C. L.; Griffith, A. J.
  3. Human Genetics. 2005, OCT; 118(1): 29-34.
  1. 12.   Novel tumor necrosis factor-knockout mice that lack Peyer's patches
  2. Kuprash, D. V.; Tumanov, A. V.; Liepinsh, D. J.; Koroleva, E. P.; Drutskaya, M. S.; Kruglov, A. A.; Shakhov, A. N.; Southon, E.; Murphy, W. J.; Tessarollo, L.; Grivennikov, S. L.; Nedospasov, S. A.
  3. European Journal of Immunology. 2005, MAY; 35(5): 1592-1600.
  1. 13.   Conditional alleles for activation and inactivation of the mouse Rx homeobox gene
  2. Voronina, V. A.; Kozlov, S.; Mathers, P. H.; Lewandoski, M.
  3. Genesis. 2005, APR; 41(4): 160-164.
  1. 14.   A common genetic variant in FCGR3A-V158F and risk of Kaposi sarcoma herpesvirus infection and classic Kaposi sarcoma
  2. Brown, E. E.; Fallin, M. D.; Goedert, J. J.; Chen, R.; Whitby, D.; Foster, C. B.; Lauria, C.; Alberg, A. J.; Messina, A.; Montella, M.; Rezza, G.; Vitale, F.; Chanock, S. J.
  3. Cancer Epidemiology Biomarkers & Prevention. 2005, MAR; 14(3): 633-637.
  1. 15.   DLC-1, a Rho GTPase-activating protein with tumor suppressor function, is essential for embryonic development
  2. Durkin, M. E.; Avner, M. R.; Huh, C. G.; Yuan, B. Z.; Thorgeirsson, S. S.; Popescu, N. C.
  3. Febs Letters. 2005, FEB 14; 579(5): 1191-1196.
  1. 16.   Microsomal epoxide hydrolase polymorphisms and risk for advanced colorectal adenoma
  2. Huang, W. Y.; Chatterjee, N.; Chanock, S.; Dean, M.; Yeager, M.; Schoen, R. E.; Hou, L. F.; Berndt, S. I.; Yadavalli, S.; Johnson, C. C.; Hayes, R. B.
  3. Cancer Epidemiology Biomarkers & Prevention. 2005, JAN; 14(1): 152-157.
  1. 17.   The effect of RANTES chemokine genetic variants on early HIV-1 plasma RNA among African American injection drug users
  2. Duggal, P.; Winkler, C. A.; An, P.; Yu, X. F.; Farzadegan, H.; O'Brien, S. J.; Beaty, T. H.; Vlahov, D.
  3. Jaids-Journal of Acquired Immune Deficiency Syndromes. 2005 38(5): 584-589.
  1. 18.   Lack of associations between HLA class II alleles and resistance to HIV-1 infection among white, non-hispanic homosexual men
  2. Liu, C. L.; Carrington, M.; Kaslow, R. A.; Gao, X. J.; Rinaldo, C. R.; Jacobson, L. P.; Margolick, J. B.; Phair, J.; Obrien, S. J.; Detels, R.
  3. Jaids-Journal of Acquired Immune Deficiency Syndromes. 2004, OCT 1; 37(2): 1313-1317.
  1. 19.   Functional characterization of the candidate tumor suppressor gene NPRL2/G21 located in 3p21.3C
  2. Li, F.; Wang, F.; Haraldson, K.; Protopopov, A.; Duh, F. M.; Geil, L.; Kuzmin, I.; Minna, J. D.; Stanbridge, E.; Braga, E.; Kashuba, V. I.; Klein, G.; Lerman, M. I.; Zabarovsky, E. R.
  3. Cancer Research. 2004, SEP 15; 64(18): 6438-6443.
  1. 20.   Animal model - Cerebellar ataxia, seizures, premature death, and cardiac abnormalities in mice with targeted disruption of the Cacna2d2 gene
  2. Ivanov, S. V.; Ward, J. M.; Tessarollo, L.; McAreavey, D.; Sachdev, V.; Fananapazir, L.; Banks, M. K.; Morris, N.; Djurickovic, D.; vor-Henneman, D. E.; Wei, M. H.; Alvord, G. W.; Gao, B. N.; Richardson, J. A.; Minna, J. D.; Rogawski, M. A.; Lerman, M. I.
  3. American Journal of Pathology. 2004, SEP; 165(3): 1007-1018.
  1. 21.   Tissue specificity of a tumor suppressor: homozygous loss of menin is well tolerated in hepatocytes
  2. Schacheri, P. C.; Crabtree, J. S.; Kennedy, A. L.; Swain, G. P.; Ward, J. M.; Marx, S. J.; Spiegel, A. M.; Collins, F. S.
  3. Journal of Internal Medicine. 2004 255(6): 721-721.
  1. 22.   Specific excision of the selenocysteine tRNA([Ser]Sec) (Trsp) gene in mouse liver demonstrates an essential role of selenoproteins in liver function
  2. Carlson, B. A.; Novoselov, S. V.; Kumaraswamy, E.; Lee, B. J.; Anver, M. R.; Gladyshev, V. N.; Hatfield, D. L.
  3. Journal of Biological Chemistry. 2004 279(9): 8011-8017.
  1. 23.   RBSP3 (HYA22) is a tumor suppressor gene implicated in major epithelial malignancies
  2. Kashuba, V. I.; Li, J. F.; Wang, F. L.; Senchenko, V. N.; Protopopov, A.; Malyukova, A.; Kutsenko, A. S.; Kadyrova, E.; Zabarovska, V. I.; Muravenko, O. V.; Zelenin, A. V.; Kisselev, L. L.; Kuzmin, I.; Minna, J. D.; Winberg, G.; Ernberg, I.; Braga, E.; Lerman, M. I.; Klein, G.; Zabarovsky, E. R.
  3. Proceedings of the National Academy of Sciences of the United States of America. 2004 101(14): 4906-4911.
  1. 24.   Two essential splice lariat branchpoint sequences in one intron in a xeroderma pigmentosum DNA repair gene: mutations result in reduced XPC mRNA levels that correlate with cancer risk
  2. Khan, S. G.; Metin, A.; Gozukara, E.; Inui, H.; Shahlavi, T.; Muniz-Medina, V.; Baker, C. C.; Ueda, T.; Aiken, J. R.; Schneider, T. D.; Kraemer, K. H.
  3. Human Molecular Genetics. 2004 13(3): 343-352.
  1. 25.   A germ-line insertion in the Birt-Hogg-Dube (BHD) gene gives rise to the Nihon rat model of inherited renal cancer
  2. Okimoto, K.; Sakurai, J.; Kobayashi, T.; Mitani, H.; Hirayama, Y.; Nickerson, M. L.; Warren, M. B.; Zbar, B.; Schmidt, L. S.; Hino, O.
  3. Proceedings of the National Academy of Sciences of the United States of America. 2004 101(7): 2023-2027.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel